摘要
本文对90例健康人,37例Graves病甲亢,11例原发性甲减,4例垂体功能减退,21例肝硬化,37例慢性肾衰和32例妊娠妇女的FT_3、FT_4、TSH-IRMA及TT_3、TT_4进行了测定。结果显示FT_3、FT_4和TT_3、TT_4在Graves病甲亢明显升高,在甲减明显降低。肝硬化、慢性肾衰患者TT_3、TT_4、FT_3、FT_4水平降低。孕妇TT_3、TT_4明显高于正常,FT_4增高,FT_3正常。妊娠后期FT_3降低。TSH-IRMA对甲亢、甲减患者甚为符合,但在妊娠时显著下降,与甲亢结果有重叠,不易鉴别。
Serum FT3, FT4, TT3 and TT4 were determined by radioimmunoassay and serum TSH was determined by immunoradiometric assay in 90 healthy subjects, 37 patients with Graves' disease, 11 patients with primary hypothyroidism, 4 patients with hypopituitarism, 21 patients with cirrhosis of the liver, 37 patients with chronic renal failure and 32 pregnant women.
The results showed that the serum FT3,FT4, TT3, TT4 levels were significantly increased in Graves'disease and decreased in primary hypothyroidism, cirrhosis of the livers, chronic renal failure. The TT3, TT4, FT4 levels were higher in pregnant women. While FT3 was normal in early pregnancy, and was lower in late pregnancy. The serum TSH-IRMA levei was higher in primary hypothyroidism and lower in Graves' disease. In pregnant women the TSH-IRMA was significantly decreased but overlapped with Graves'disease,
出处
《北京医学》
CAS
北大核心
1992年第1期16-18,共3页
Beijing Medical Journal
